Jill R. Glausier

Jill R. Glausier

Auto-generated profile, based on publicly available information

Jill R. Glausier

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
BPBaDoi Phan
BaDoi Phan
MRMadelyn H. Ray
Madelyn H. Ray
XXXiangning Xue
Xiangning Xue
CFChen Fu
Chen Fu
RFRobert J. Fenster
Robert J. Fenster
RLRyan W. Logan
Ryan W. Logan
In brain, the striatum is a heterogenous region involved in reward and goal-directed behaviors. Striatal dysfunction is linked to psychiatric disorders, including opioid use disorder (OUD). Striatal subregions are divided based on neuroanatomy, each with unique roles in OUD. In OUD, the dorsal striatum is involved in altered reward processing, formation of habits, and development of negative affect during withdrawal. Using single nuclei RNA-sequencing, we identified both canonical (e.g., dopamine receptor subtype) and less abundant cell populations (e.g., interneurons) in human dorsal striatum. Pathways related to neurodegeneration, interferon response, and DNA damage were significantly enriched in striatal neurons of individuals with OUD. DNA damage markers were also elevated in striatal neurons of opioid-exposed rhesus macaques. Sex-specific molecular differences in glial cell subtypes associated with chronic stress were found in OUD, particularly female individuals. Together, we describe different cell types in human dorsal striatum and identify cell type-specific alterations in OUD.

18 June 2025 in Nature
Verified
Journal Article
Open access
PDF file
AHAhyeon Hwang
Ahyeon Hwang
MSMario Skarica
Mario Skarica
SXSiwei Xu
Siwei Xu
JCJensine Coudriet
Jensine Coudriet
CLChe Yu Lee
Che Yu Lee
MGMatthew J. Girgenti
Matthew J. Girgenti
Post-traumatic stress disorder (PTSD) is a polygenic disorder occurring after extreme trauma exposure. Recent studies have begun to detail the molecular biology of PTSD. However, given the array of PTSD-perturbed molecular pathways identified so far1, it is implausible that a single cell type is responsible. Here we profile the molecular responses in over two million nuclei from the dorsolateral prefrontal cortex of 111 human brains, collected post-mortem from individuals with and without PTSD and major depressive disorder. We identify neuronal and non-neuronal cell-type clusters, gene expression changes and transcriptional regulators, and map the epigenomic regulome of PTSD in a cell-type-specific manner. Our analysis revealed PTSD-associated gene alterations in inhibitory neurons, endothelial cells and microglia and uncovered genes and pathways associated with glucocorticoid signalling, GABAergic transmission and neuroinflammation. We further validated these findings using cell-type-specific spatial transcriptomics, confirming disruption of key genes such as SST and FKBP5. By integrating genetic, transcriptomic and epigenetic data, we uncovered the regulatory mechanisms of credible variants that disrupt PTSD genes, including ELFN1, MAD1L1 and KCNIP4, in a cell-type-specific context. Together, these findings provide a comprehensive characterization of the cell-specific molecular regulatory mechanisms that underlie the persisting effects of traumatic stress response on the human prefrontal cortex.

1 March 2017 in Schizophrenia Research
Verified
Journal Article
Closed access
JGJill R. Glausier
Jill R. Glausier
DLDavid A. Lewis
David A. Lewis

28 April 2021 in Aging Cell
Verified
Journal Article
Open access
PDF file
SBSilas A. Buck
Silas A. Buck
TSThomas Steinkellner
Thomas Steinkellner
DADespoina Aslanoglou
Despoina Aslanoglou
MVMichael Villeneuve
Michael Villeneuve
SBSai H. Bhatte
Sai H. Bhatte
ZFZachary Z. Freyberg
Zachary Z. Freyberg
Age is the greatest risk factor for Parkinson's disease (PD) which causes progressive loss of dopamine (DA) neurons, with males at greater risk than females. Intriguingly, some DA neurons are more resilient to degeneration than others. Increasing evidence suggests that vesicular glutamate transporter (VGLUT) expression in DA neurons plays a role in this selective vulnerability. We investigated the role of DA neuron VGLUT in sex‐ and age‐related differences in DA neuron vulnerability using the genetically tractable Drosophila model. We found sex differences in age‐related DA neurodegeneration and its associated locomotor behavior, where males exhibit significantly greater decreases in both DA neuron number and locomotion during aging compared with females. We discovered that dynamic changes in DA neuron VGLUT expression mediate these age‐ and sex‐related differences, as a potential compensatory mechanism for diminished DA neurotransmission during aging. Importantly, female Drosophila possess higher levels of VGLUT expression in DA neurons compared with males, and this finding is conserved across flies, rodents, and humans. Moreover, we showed that diminishing VGLUT expression in DA neurons eliminates females' greater resilience to DA neuron loss across aging. This offers a new mechanism for sex differences in selective DA neuron vulnerability to age‐related DA neurodegeneration. Finally, in mice, we showed that the ability of DA neurons to achieve optimal control over VGLUT expression is essential for DA neuron survival. These findings lay the groundwork for the manipulation of DA neuron VGLUT expression as a novel therapeutic strategy to boost DA neuron resilience to age‐ and PD‐related neurodegeneration.

20 September 2015 in Schizophrenia Bulletin
Verified
Journal Article
Open access
PDF file
IGIsobel W. Green
Isobel W. Green
JGJill R. Glausier
Jill R. Glausier
Schizophrenia is a clinically heterogeneous disorder that is perhaps more accurately characterized as “the schizophrenia syndrome.” This clinical heterogeneity is reflected in the heterogeneous neurobiological presentations associated with the illness. Moreover, even highly specific neural aberrations that are associated with distinct symptoms of schizophrenia are linked to a wide range of risk factors. As such, any individual with schizophrenia likely has a particular set of risk factors that interact and converge to cross the disease threshold, forming a particular etiology that ultimately generates a core pathophysiology. This core pathophysiology may then produce 1 or more symptoms of schizophrenia, leading to common symptoms across individuals in spite of disparate etiologies. As such, the schizophrenia syndrome can be considered as an equifinal entity: a state of dysfunction that can arise from different upstream etiologies. Moreover, schizophrenia etiologies are multifactorial and can involve the interactive effects of a broad range of genetic, environmental, and developmental risk factors. Through a consideration of how disparate etiologies, caused by different sets of risk factors, converge on the same net dysfunction, this paper aims to model the equifinal nature of schizophrenia symptoms. To demonstrate the equifinal model, we discuss how maternal infection and adolescent cannabis use, 2 recognized schizophrenia risk factors, may interact with other genetic, environmental, and/or developmental risk factors to cause the conserved clinical presentation of impaired working memory.

25 June 2025 in Nature Mental Health
Verified
Journal Article
Closed access
PDF file
AAAna C. Andreazza
Ana C. Andreazza
LBL. Felipe Barros
L. Felipe Barros
ABAlexander Behnke
Alexander Behnke
DBDorit Ben-Shachar
Dorit Ben-Shachar
SBSabina Berretta
Sabina Berretta
Corey WeistuchCorey Weistuch
Corey Weistuch